Header Logo

Connection

Chun Chao to Uterine Cervical Neoplasms

Back to Details
This is a "connection" page, showing publications Chun Chao has written about Uterine Cervical Neoplasms.
Chun Chao
Connection Strength
5.067
Uterine Cervical Neoplasms
  1. Primary Human Papillomavirus Screening: Women's Perceptions of New Cervical Cancer Screening Recommendations. J Womens Health (Larchmt). 2024 Dec; 33(12):1614-1624.
    View in: PubMed
    Score: 0.855
  2. A study protocol for a cluster randomized pragmatic trial for comparing strategies for implementing primary HPV testing for routine cervical cancer screening in a large health care system. Contemp Clin Trials. 2023 01; 124:106994.
    View in: PubMed
    Score: 0.752
  3. Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings. Cancer Med. 2023 Feb; 12(3):3705-3717.
    View in: PubMed
    Score: 0.745
  4. Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21-65 Years in a Large Integrated Health Care System - Southern California, January 1-September 30, 2019, and January 1-September 30, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 29; 70(4):109-113.
    View in: PubMed
    Score: 0.666
  5. Adherence to Cervical Cancer Screening Guidelines Among Women Aged 66-68 Years in a Large Community-Based Practice. Am J Prev Med. 2019 12; 57(6):757-764.
    View in: PubMed
    Score: 0.614
  6. Patterns and correlates of cervical cancer screening initiation in a large integrated health care system. Am J Obstet Gynecol. 2018 04; 218(4):429.e1-429.e9.
    View in: PubMed
    Score: 0.537
  7. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system. Am J Obstet Gynecol. 2017 Feb; 216(2):151.e1-151.e9.
    View in: PubMed
    Score: 0.494
  8. Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women. Vaccine. 2020 06 15; 38(29):4520-4523.
    View in: PubMed
    Score: 0.159
  9. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium. J Natl Cancer Inst. 2020 03 01; 112(3):238-246.
    View in: PubMed
    Score: 0.156
  10. Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med. 2012 Feb; 271(2):193-203.
    View in: PubMed
    Score: 0.088

© 2025 Kaiser Permanente